医疗保健 · Healthcare
打开互动页面（K 线、成交价图）Open interactive page →
CTNM · Contineum Therapeutics, Inc.
内部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
Contineum Therapeutics, Inc.（CTNM）内部人交易：2026-07-01 至 2026-10-22，内部人公开市场买入 —、卖出 $1.1M；高管董事有效买入 —、有效卖出 —。最近申报 2026-09-08。
买入 Bought—
卖出 Sold$1.1M
有效买入 Effective bought—
有效卖出 Effective sold—
最近申报 Recent filings
| 交易日 | 内部人 | 类型 | 股数 | 价格 | 金额 | |
|---|---|---|---|---|---|---|
| 2026-09-08 | Stengone Carmine N. CEO and President, Director | 卖出 Sell | 2,500 | $16.46 | $41K | SEC |
| 2026-08-03 | Stengone Carmine N. CEO and President, Director | 卖出 Sell | 2,500 | $16.01 | $40K | SEC |
| 2026-07-08 | Lorrain Daniel S. Chief Scientific Officer | 卖出 Sell | 1,040 | $16.00 | $17K | SEC |
| 2026-07-08 | Stengone Carmine N. CEO and President, Director | 卖出 Sell | 2,500 | $16.00 | $40K | SEC |
| 2026-06-30 | Lorrain Daniel S. Chief Scientific Officer | 卖出 Sell | 37,179 | $15.99 | $595K | SEC |
| 2026-06-30 | Stengone Carmine N. CEO and President, Director | 卖出 Sell | 10,000 | $16.01 | $160K | SEC |
| 2026-06-30 | Watkins Tim CMO & Head of Development | 卖出 Sell | 10,833 | $16.02 | $174K | SEC |
「有效」= 高管或董事的公开市场主动买卖，排除 10b5-1 计划、行权卖出、缴税卖出、IPO/认购等。
拟出售 Form 144
| 预计出售日 | 申报人 | 股数 | 约金额 | |
|---|---|---|---|---|
| 2026-10-01 | Lorrain Daniel S. Officer | 4,170 | $56K | 10b5-1 |
| 2026-09-08 | Stengone Carmine N. Director, Officer | 2,500 | $42K | 10b5-1 |
| 2026-09-01 | Lorrain Daniel S. Officer | 9,520 | $155K | 10b5-1 |
| 2026-08-03 | Lorrain Daniel S. Officer | 9,520 | $147K | 10b5-1 |
| 2026-08-03 | Stengone Carmine N. Director, Officer | 2,500 | $39K | 10b5-1 |
| 2026-07-08 | Stengone Carmine N. Director, Officer | 2,500 | $36K | 10b5-1 |
| 2026-07-01 | Lorrain Daniel S. Officer | 9,520 | $156K | 10b5-1 |
内部人 Insiders
Stengone Carmine N.、Lorrain Daniel S.、Watkins Tim